Gene Therapy of the Central Nervous System: From Bench to Bedside

1st Edition

Editors: Michael Kaplitt Matthew During
Hardcover ISBN: 9780123976321
eBook ISBN: 9780080454375
Imprint: Academic Press
Published Date: 11th November 2005
Page Count: 370
235.00 + applicable tax
145.00 + applicable tax
180.00 + applicable tax
215.00 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Description

Few areas of biomedical research provide greater opportunities for radically new therapies for devastating diseases that have evaded treatment so far than gene therapy. This is particularly true for the brain and nervous system, where gene transfer has become a key technology for basic research and has recently been translated to human therapy in several landmark clinical trials.

Gene Therapy of the Central Nervous System: From Bench to Bedside represents the first definitive volume on this subject. Edited by two pioneers of neurological gene therapy, this volume contains contributions by leaders who helped create this field and are expanding the promise of gene therapy for the future of basic and clinical neuroscience. Drawing upon this extensive collective experience, this book provides clear and informative reviews on a variety of subjects of interest to anyone exploring or using gene therapy for neurobiological applications in research and clinical praxis.

Key Features

  • Presents gene transfer technologies with particular emphases upon novel vehicles, immunological issues and the role of gene therapy in stem cells
  • Discusses preclinical areas that are likely to translate into clinical studies in the near future, including epilepsy, pain and amyotrophic lateral sclerosis
  • Includes "insider" information on technological and regulatory issues which can often limit effective translation of even the most promising idea into clinical use

Readership

Neuroscientists, geneticists, molecular biologists, pharmaceutical companies

Table of Contents

SECTION I. GENE TRANSFER TECHNOLOGY AND REGULATORY ISSUES

  1. Design and optimization of expression cassettes including promoter choice and regulatory lements
  2. Identification of Novel AAV Serotypes for Use as Vectors
  3. HSV amplicon vectors for gene delivery to the nervous system
  4. Influence of the immune system on CNS gene transfer
  5. Targeted induction of endogenous neural stem and progenitor cells: A new strategy for gene therapy of neurological disease
  6. Neurosurgical Targeting, Delivery and Infusion of Gene Therapy Agents in the Brain
  7. Gene Transfer for Neurological Disease: Agencies, Policies and Process

SECTION II. GENE THERAPY FOR DEGENERATIVE AND FUNCTIONAL DISORDERS

  1. Gene therapy for Parkinson’s disease
  2. Non human primate models for testing gene therapy for neurodegenerative disorders
  3. Delivery of Molecular Therapeutics into the CNS and their Distribution within the Brain
  4. Gene therapy for CNS diseases using intrabodies
  5. Gene therapy for epilepsy

SECTION IIII. PSYCHIATRIC AND BEHAVIORAL GENE THERAPY

  1. Genetic manipulation of learning and memory
  2. Psychiatric applications of viral vectors
  3. Use of viral vectors to influencebehavior

SECTION IV. GENE THERAPY FOR PAIN AND SPINAL CORD DISEASES

  1. Herpes simplex vector mediated gene transfer to the peripheral nervous system for the treatment of polyneuropathy and chronic pain
  2. Characterization of pain receptors in the spinal cord using a viral vector for spatial-temportal gene targeting
  3. Viral vector mediated gene therapy of pain
  4. VEGF, an angiogenic factor with neurotrophic activity, useful for treatment of ALS?
  5. Viral Vec

Details

No. of pages:
370
Language:
English
Copyright:
© Academic Press 2006
Published:
Imprint:
Academic Press
eBook ISBN:
9780080454375
Hardcover ISBN:
9780123976321

About the Editor

Michael Kaplitt

Affiliations and Expertise

New York Hospital, Cornell University Medical College and Laboratory of Neurobiology and Behavior, The Rockefeller University, New York, U.S.A.

Matthew During